Mark Li

Mark Li, PhD, is currently an Associate Director at Eli Lilly, where they manage clinical laboratory sciences and vendor oversight. Previously, they served as a Research Advisor at Eli Lilly, focusing on immunogenicity assessment, and held positions as a Senior Lead Scientist and Principal Investigator at Labcorp Drug Development, overseeing bioanalysis for preclinical and clinical trials. Mark also worked as a Research Scientist at Purdue University Center for Drug Discovery and completed postdoctoral research at Academia Sinica, Taiwan, and Purdue University. They are pursuing advanced degrees in life sciences and biotechnology, highlighting a strong commitment to the field of clinical bioanalysis.